Fabino Enterprises Share Price Today | Stock Price & Fabino Enterprises Share Screener
Track the current Fabino Enterprises share price and stock price live with TickJournal's free stock screener. Track Fabino Enterprises market cap to gauge the company's total market size. Use the Fabino Enterprises stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Fabino Enterprises opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Fabino Enterprises Share Price Chart
Track the current stock price of Fabino Enterprises with an interactive chart. Analyse FABINO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Fabino Enterprises stock quote in one place.
Fabino Enterprises Company Profile - Fundamental Screener
Screen Fabino Enterprises company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for FABINO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0DRT01018.
Company Details
Classification
Identifiers and Leadership
Fabino Enterprises Balance Sheet Screener
Screen FABINO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2025, total assets were ₹18 against total liabilities of ₹18, up from ₹15 in 2024.
Latest statistics put total assets at ₹18 and shareholder funds at ₹4, with a leverage ratio of 0.37.
| Item | 2025 | 2024 | 2023 |
|---|---|---|---|
Assets |
|||
| Total Assets | 18 | 15 | 5 |
| Current Assets | 17 | 15 | 5 |
| Fixed Assets | 1 | 0 | 0 |
Liabilities |
|||
| Total Liabilities | 18 | 15 | 5 |
| Current Liabilities | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 |
Shareholders' Equity |
|||
| Total Equity | 4 | 4 | 4 |
| Share Capital | 2 | 2 | 2 |
| Reserves & Surplus | 2 | 2 | 2 |
Fabino Enterprises Income Statement Screener - Profit & Revenue Analysis
Screen Fabino Enterprises income statement and profit fundamentals. Analyze FABINO quarterly results. Fabino Enterprises reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2025-March, shows revenue of ₹18 and net profit of ₹0.
| Item | None-None | 2025-March | 2024-March | 2023-March |
|---|---|---|---|---|
Revenue and Expenses | ||||
| Revenue | 0 | 18 | 21 | 3 |
| Expenses | 0 | 18 | 21 | 3 |
Operating Costs and Margins | ||||
| EBITDA | 0 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 1.00% | 1.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 |
Profit and Earnings | ||||
| Profit Before Tax | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 |
| EPS | 0.00 | 0.29 | 0.17 | 0.05 |
Fabino Enterprises Cash Flow Screener - Liquidity Fundamentals
Screen FABINO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities generated ₹0.
Over the same period, investing activities provided ₹0 and financing activities provided ₹1.
| Item | 2025-March | 2024-March |
|---|---|---|
Cash from Operations and Investing | ||
| Operating Activities | 0 | -1 |
| Investing Activities | 0 | 0 |
Financing and Net Cash | ||
| Financing Activities | 1 | 1 |
| Net Cash Flow | 0 | 0 |
Fabino Enterprises Shareholding Pattern Screener
See Fabino Enterprises shareholding pattern with promoter, FII, and DII holdings. Check Fabino Enterprises promoter holding and ownership changes for FABINO on TickJournal, and see how institutional stock price moves affect the market.
In 2025-Mar, promoters held 56.82%, foreign institutions 0.00%, domestic institutions 0.00% and the public 29.18%, spread across 137 shareholders.
The shareholder count was 137 in 2025-Mar, compared with 129 in 2025-Sept.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Mar | 2022-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 56.82% | 56.82% | 56.82% | 56.82% | 56.82% | 56.82% | 56.82% | 56.82% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 29.18% | 28.75% | 26.18% | 28.18% | 28.32% | 27.61% | 32.04% | 28.32% |
| Other Holding | 14.00% | 14.43% | 17.00% | 15.00% | 14.86% | 15.57% | 11.14% | 14.86% |
| Shareholder Count | 137 | 129 | 138 | 138 | 160 | 151 | 195 | 168 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Fabino Enterprises. Fabino Enterprises dividend yield can be compared with peers and other stocks in the market.
Fabino Enterprises Stock Index Membership - Nifty & Sensex
See which indices include Fabino Enterprises stock. Check FABINO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Fabino Enterprises Market Events Screener - Corporate Actions
Get Fabino Enterprises corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Fabino Enterprises stock events that may affect FABINO share price, along with derivatives, futures and options activity and sector gainers.
6 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 13, 2025, with a record date of November 13, 2025.
It is followed by Annual General Meeting dated September 22, 2025 and Quarterly Result Announcement dated May 29, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 0.00% |
| 2025-09-22 | 2025-09-22 | Annual General Meeting | NA | -2.00% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.00% |
| 2024-10-21 | 2024-10-21 | Quarterly Result Announcement | NA | 0.00% |
| 2024-09-16 | 2024-09-16 | Annual General Meeting | NA | 9.09% |
| 2024-06-19 | 2024-06-19 | Change Of Name | NA | 0.00% |
Fabino Enterprises Competitors Screener - Peer Stocks Comparison
Screen FABINO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 41.99 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 54.95 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 64.03 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 43.36 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 50.22 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 58.72 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 41.66 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 47.28 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 55.09 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 44.89 |
Fabino Enterprises Company Announcements - News & Reports Screener
Screen FABINO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated November 13, 2025.
The next most recent announcements are dated November 13, 2025 and November 10, 2025.
| Date | Update | Actions |
|---|---|---|
| 2025-11-13 | Results- Financial Results For The Half Year Ended September 30 2025 | - |
| 2025-11-13 | Board Meeting Outcome for Outcome Of Board Meeting & Submission Of Unaudited Financial Results For Half Year Ended September 30 2025 | - |
| 2025-11-10 | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For Half Year Ended September 30 2025 | - |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-09-25 | Closure of Trading Window | - |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-09-22 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-08-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-08-29 | Intimation Of Book Closure For 14Th Annual General Meeting | - |
| 2025-08-29 | Reg. 34 (1) Annual Report. | - |
| 2025-08-29 | Notice Of 14Thannual General Meeting (AGM) To Be Held On Monday September 22 2025 | - |
| 2025-08-28 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2025-08-28 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2025-08-28 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday August 28 2025 | - |
| 2025-07-16 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-06-20 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2025-06-20 | Board Meeting Outcome for Outcome Of The Board Meeting Held On June 20 2025. | - |
| 2025-05-29 | Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer | - |
| 2025-05-29 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2025-05-29 | Results For The Financial Year Ended March 31 2025 | - |
Frequently Asked Questions
How is the company valued right now?
The P/B ratio is 1.04. Market capitalisation stands at ₹3.55 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on November 20, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 2 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.